Literature DB >> 26411420

Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation.

Christian Pfluecke1, Daniel Tarnowski2, Lina Plichta2, Katharina Berndt2, Paul Schumacher2, Stefan Ulbrich2, Mathias Forkmann2, Marian Christoph2, David M Poitz2, Carsten Wunderlich2, Ruth H Strasser2, Karim Ibrahim2.   

Abstract

BACKGROUND: A strong interdependence is known between atrial fibrillation (AF), inflammation and thrombogenesis. Monocyte-platelet aggregates (MPAs) are sensitive markers of platelets and monocyte activation. It is not known whether MPAs are associated with thrombogenicity in AF. Therefore, we examined differences in the content of MPAs and CD11b expression in patients with AF in dependence of the presence of atrial thrombus formation.
METHODS: 107 patients with symptomatic AF underwent transesophageal echocardiography (TEE) before planned cardioversion or pulmonary vein isolation. Flow-cytometric quantification analysis was done on the day of performed TEE to determine the content of MPAs and the expression of CD11b on monocytes and granulocytes.
RESULTS: Compared to patients without thrombus (n = 80) those with an echocardiographic proven left atrium (LA) thrombus (n = 27) showed an increased extent of the risk factors age, diabetes and heart failure. The content of MPAs (147 ± 12 vs. 311 ± 29 cells/µl, p < 0.001) as well as the CD11b expression on monocytes (p < 0.05) and granulocytes (p < 0.05) were strongly associated with the existence of a LA thrombus. The content of MPAs and the CD11b expression remained independent predictors for LA thrombus after adjustment in logistic regression analysis and negatively correlated with left atrial appendage flow velocity. MPAs above 170 cells/µl (OR 34.2, p = 0.01) had a sensitivity of 96 % and a specificity of 73 % for predicting LA-thrombus.
CONCLUSIONS: The content of MPAs and the CD11b expression on monocytes and granulocytes are increased in AF-patients with proven thrombus formation. They seem to be appropriate biomarkers for stratification of thromboembolic risk in patients with AF.

Entities:  

Keywords:  Atrial fibrillation; Monocytes; Monocyte–platelet aggregates; Stroke, thromboembolism, inflammation; Thrombogenicity

Mesh:

Substances:

Year:  2015        PMID: 26411420     DOI: 10.1007/s00392-015-0922-4

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  48 in total

1.  Tissue factor, the emerging link between inflammation, thrombosis, and vascular remodeling.

Authors:  M S Penn; E J Topol
Journal:  Circ Res       Date:  2001-07-06       Impact factor: 17.367

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Usefulness of high-sensitivity C-reactive protein to predict mortality in patients with atrial fibrillation (from the Atherosclerosis Risk In Communities [ARIC] Study).

Authors:  José Hermida; Faye L Lopez; Ramón Montes; Kunihiro Matsushita; Brad C Astor; Alvaro Alonso
Journal:  Am J Cardiol       Date:  2011-09-29       Impact factor: 2.778

4.  Upregulation of CD40 ligand and enhanced monocyte-platelet aggregate formation are associated with worse clinical outcome after ischaemic stroke.

Authors:  Maria Lukasik; Grzegorz Dworacki; Joanna Kufel-Grabowska; Cezary Watala; Wojciech Kozubski
Journal:  Thromb Haemost       Date:  2012-01-11       Impact factor: 5.249

5.  Specific accumulation of circulating monocytes and polymorphonuclear leukocytes on platelet thrombi in a vascular injury model.

Authors:  D Kirchhofer; M A Riederer; H R Baumgartner
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

6.  Fibrin(ogen) is internalized and degraded by activated human monocytoid cells via Mac-1 (CD11b/CD18): a nonplasmin fibrinolytic pathway.

Authors:  D I Simon; A M Ezratty; S A Francis; H Rennke; J Loscalzo
Journal:  Blood       Date:  1993-10-15       Impact factor: 22.113

7.  Increased formation of monocyte-platelet aggregates in ischemic heart failure.

Authors:  Benjamin J Wrigley; Eduard Shantsila; Luke D Tapp; Gregory Y H Lip
Journal:  Circ Heart Fail       Date:  2012-11-14       Impact factor: 8.790

8.  Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm.

Authors:  Han S Lim; Scott R Willoughby; Carlee Schultz; Cheryl Gan; Muayad Alasady; Dennis H Lau; Darryl P Leong; Anthony G Brooks; Glenn D Young; Peter M Kistler; Jonathan M Kalman; Matthew I Worthley; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2013-01-16       Impact factor: 24.094

9.  The efficacy and dosage effect of corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a systematic review.

Authors:  Paul E Marik; Robert Fromm
Journal:  J Crit Care       Date:  2009-02-13       Impact factor: 3.425

10.  Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.

Authors:  Gabriella Passacquale; Padman Vamadevan; Luis Pereira; Colleen Hamid; Valerie Corrigall; Albert Ferro
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

View more
  10 in total

Review 1.  Coagulation Abnormalities in Heart Failure: Pathophysiology and Therapeutic Implications.

Authors:  Ju H Kim; Palak Shah; Udaya S Tantry; Paul A Gurbel
Journal:  Curr Heart Fail Rep       Date:  2016-12

2.  Impaired Production and Diurnal Regulation of Vascular RvDn-3 DPA Increase Systemic Inflammation and Cardiovascular Disease.

Authors:  Romain A Colas; Patricia R Souza; Mary E Walker; Maudrian Burton; Zbigniew Zasłona; Annie M Curtis; Raquel M Marques; Jesmond Dalli
Journal:  Circ Res       Date:  2018-02-05       Impact factor: 17.367

3.  13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis.

Authors:  Mary E Walker; Patricia R Souza; Romain A Colas; Jesmond Dalli
Journal:  FASEB J       Date:  2017-05-02       Impact factor: 5.191

4.  Inflammation and the risk of atrial high-rate episodes (AHREs) in patients with cardiac implantable electronic devices.

Authors:  Daniele Pastori; Kazuo Miyazawa; Yanguang Li; Farhan Shahid; Hussein Hado; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2018-04-17       Impact factor: 5.460

5.  Papain Ameliorates the MPAs Formation-Mediated Activation of Monocytes by Inhibiting Cox-2 Expression via Regulating the MAPKs and PI3K/Akt Signal Pathway.

Authors:  Xianming Fei; Wufeng Yuan; Yan Zhao; Huan Wang; Shi Bai; Qinghua Huang
Journal:  Biomed Res Int       Date:  2018-10-16       Impact factor: 3.411

Review 6.  Platelet-Leucocyte Aggregates as Novel Biomarkers in Cardiovascular Diseases.

Authors:  Kinga Pluta; Kinga Porębska; Tomasz Urbanowicz; Aleksandra Gąsecka; Anna Olasińska-Wiśniewska; Radosław Targoński; Aleksandra Krasińska; Krzysztof J Filipiak; Marek Jemielity; Zbigniew Krasiński
Journal:  Biology (Basel)       Date:  2022-01-30

7.  Predictive value of lymphocyte-to-monocyte ratio in critically Ill patients with atrial fibrillation: A propensity score matching analysis.

Authors:  Yue Yu; Suyu Wang; Pei Wang; Qiumeng Xu; Yufeng Zhang; Jian Xiao; Xiaofei Xue; Qian Yang; Wang Xi; Junnan Wang; Renhong Huang; Meiyun Liu; Zhinong Wang
Journal:  J Clin Lab Anal       Date:  2021-12-30       Impact factor: 2.352

Review 8.  Exosomes in atrial fibrillation: therapeutic potential and role as clinical biomarkers.

Authors:  Kun Xiang; Muhammad Akram; Walaa Fikry Elbossaty; Jinfu Yang; Chengming Fan
Journal:  Heart Fail Rev       Date:  2021-07-12       Impact factor: 4.654

9.  Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.

Authors:  Christina Christersson; Lars Wallentin; Ulrika Andersson; John H Alexander; Marco Alings; Raffaele De Caterina; Bernard J Gersh; Christopher B Granger; Sigrun Halvorsen; Michael Hanna; Kurt Huber; Elaine M Hylek; Renato D Lopes; Byung-Hee Oh; Agneta Siegbahn
Journal:  Heart       Date:  2018-09-12       Impact factor: 5.994

10.  CD11b expression on monocytes and data of inflammatory parameters after Transcatheter Aortic Valve Implantation in dependence of early mortality.

Authors:  C Pfluecke; S Wydra; K Berndt; D Tarnowski; M Cybularz; P Barthel; A Linke; K Ibrahim; D M Poitz
Journal:  Data Brief       Date:  2020-06-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.